|
|
Article: U.S. Patent Disclosures.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
ARC Pharmaceuticals Inc., of Vancouver, was granted U.S. Patent No. 6,812,220, titled "Pharmaceutical Compositions and Methods Relating to Fucans." The patent protects property licensed to ARC that might be used in the development of its lead product candidates to treat surgical adhesions.
Bioniche Life Sciences Inc., of Belleville, Ontario, was granted U.S. Patent No. 6,890,911, titled "Method for the treatment of inflammation," relating to its core mycobacterial cell wall technology. The patent covers the Mycobacterial Cell Wall-DNA Complex, which has been shown to possess immunomodulatory, vaccine adjuvant and chemotherapeutic activities.
BioVisioN ...